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http://dx.doi.org/10.1016/j.pedneo.2An acute viral infection may lead to death, as seen in the recent novel 2009 influenza A (H1N1)
virus pandemic that rapidly spread worldwide. Hemophagocytic lymphohistiocytosis (HLH) is a
systemic disorder with high mortality rates and can be triggered by various etiological agents,
including viral infections. H1N1-associated HLH is a very rare condition that may cause
extremely severe complications leading to multiple organ failure (MOF) and death. We report
an unusual case of a rapidly progressive and fatal H1N1 infection that was complicated with
HLH and MOF in a previously healthy 8-year-old Asian female who initially presented with fever
and abdominal pain. To enable early recognition and proper treatment, physicians should be
aware of the possibility of this fatal complication, which may present with unusual initial
symptoms.
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In early April 2009, the US Centers for Disease Control and
Prevention reported novel swine influenza A (H1N1) infectioned by Elsevier Taiwan LLC. All rights reserved.
Table 1 Laboratory investigation results of the child.
Investigations 1st day 2nd day
Hemoglobin (g/dL) 8.5 8.0
WBC (/mm3) 2900 2500
Neutrophils (%) 59.0 69.6
Lymphocytes (%) 38.0 27.4
Monocytes (%) 2.0 2
Platelets (/mm3) 29,000 22,000
PT (s) 16 45
PTT (s) 60 80
Serum ferritin level (ng/dL) 12,000 12,200
Serum triglycerides (mg/dL) 390 400
ESR (mm/h) 15 d
C-reactive protein (mg/dL) 14.78 d
Liver function
Total bilirubin (mg/dL) 2 9
Aspartate aminotransferase (U/L) 280 1200
190 B. Shrestha et alin two children. The virus promptly became a pandemic and
caused 2500e6000 deaths.1,2 Hemophagocytic lymphohistio-
cytosis (HLH) is a rare but potentially fatal disorder, charac-
terized by a fulminant picture of nonremitting high fever,
pancytopenia, hepatosplenomegaly, lymphadenopathy, liver
dysfunction, coagulopathy, and neurological symptoms or
encephalopathy; it can be explained by high amounts of
proinflammatorycytokines suchas interferon-gamma (IFN-g),
interleukin (IL)-1, IL-6, and tumor necrosis factor-alpha (TNF-
a) resulting in the clinical characteristics of a cytokine
storm.3e5 Beutel et al6 considered HLH associated with
influenza A (H1N1) infection to be strongly associated with
multiple organ failure (MOF) and death. There are very few
reports of influenza-induced HLH in children.7,8 We report an
unusual case of a rapidly progressive H1N1 infection that
presented with unusual initial symptoms of fever and
abdominal pain and was complicated by HLH and fatal MOF in
a previously healthy 8-year-old female.Alanine aminotransferase (U/L) 150 450
Serum albumin (g/dL) 3.5 3.4
Sodium (mg/dL) 135 125
Potassium (mg/dL) 3.5 5




ESRZ erythrocyte sedimentation rate; PTZ prothrombin time;
PTT Z partial thromboplastin time; WBC Z white blood cells.2. Case Report
An 8-year-old Asian female presented on September 25,
2009 with acute colicky abdominal pain, rhinorrhea, a mild
cough, and a high-grade fever that had been present for 4
days. On admission, the patient was conscious and coop-
erative, but restless, with a core body temperature of
39.7C, pulse of 140 beats per minute, respiratory rate of
23 breaths per minute, and blood pressure of 90/45 mmHg.
Skin examination showed no jaundice, pallor, cyanosis,
rash, or purpuric lesions. There was generalized lymph-
adenopathy. An abdominal examination revealed a tender
abdomen, and hepatosplenomegaly was noted, with the
liver edge palpated at 3 cm below the right costal margin
and the spleen palpated at 3 cm below the left costal
margin. There were no clinically detectable ascites. The
chest and cardiac examinations revealed no abnormalities.
Results of the laboratory investigation are summarized in
Table 1. A chest X-ray was normal (Figure 1A), and
abdominal ultrasonography revealed liver and spleen
enlargement, gallbladder wall edema, peripancreatic
retroperitoneal lymph node enlargement, and mild ascites.
A computed tomography (CT) scan of the abdomen
confirmed the ultrasonographic findings (Figure 1B). Sur-
prisingly, bone marrow aspiration, which was performed to
exclude malignancy, revealed typical hemophagocytosis
(Figure 1C). A throat swab specimen was collected and sent
for analysis for pandemic influenza A (H1N1) 2009 virus [by
reverse-transcription ploymerase chain reaction (RT-PCR)].
Based on the persistent fever, hepatosplenomegaly,
pancytopenia, hyperferritinemia, hypertriglyceridemia,
and hemophagocytosis in the bone marrow, HLH was diag-
nosed. Treatment was started with rehydration, omepra-
zole, methylprednisolone at 30 mg/kg/dose, and
intravenous immunoglobulins (IVIG) at 400 mg/kg/day.
On the 2nd day after admission, the child was transferred
to the pediatric intensive care unit due to a rapid deteri-
oration in her general condition, persistence of fever,
development of generalized tonic colonic convulsions,
jaundice, multiple purpuric eruptions, oliguria, and
cyanosis with a percutaneous oxygen saturation rate that
dropped to 67%. At this stage, the child was ventilatedmechanically. The majority of the laboratory values dete-
riorated, as summarized in Table 1. That day, the patient
died from MOF. Throat swab specimens were found to be
positive for pandemic influenza A (H1N1) 2009 virus by RT-
PCR, but unfortunately, these results were not available
until after the patient died.
3. Discussion
HLH is a life-threatening condition caused by excessive
activation and proliferation of T cells and macrophages.9
These cellular responses can be triggered by a variety of
viral, bacterial, fungal, and parasitic infections, as well as
by genetic conditions, collagen-vascular diseases, and
malignancies.4
Infection-related HLH is most commonly caused by viral
infections; in Taiwanese patients with infection-related
HLH, mortality rates were approximately 50e60%.10e12
Despite aggressive treatment, most patient deaths resul-
ted from refractory bleeding, pulmonary edema, and
MOF.12
In 2009, novel human influenza A (H1N1) became a
pandemic, which started in Mexico and spread worldwide.
The mortality rates from infections with H1N1 were higher
in patients who developed HLH and MOF.
The clinical presentation of HLH is usually acute and can
be dramatic, causing fatalities. Typically, most clinical
features and laboratory findings can be explained by the
widespread dissemination of hyperactivated lymphocytes
and macrophages, and are compatible with the biologic
effects of several T-lymphocyte- and macrophage-derived
Figure 1 (A) Normal chest x-ray; (B) CT of the abdomen demonstrating hepatomegaly (1) and splenomegaly (2); and (C) bone
marrow smears demonstrating hemophagocytosis. CT Z computed tomography.
H1N1-associated hemophagocytic lymphohistiocytosis 191proinflammatory cytokines, such as IFN-g, IL-1, IL-6, and
TNF-a.3
According to the guidelines of the International Histio-
cyte Society, the diagnosis of HLH requires the presence of
at least five of the following eight criteria: fever, spleno-
megaly, cytopenias, hypertriglyceridemia and/or hypofi-
brinogenemia, hyperferritinemia, elevated soluble IL-2
receptor alpha (IL-2Ra) levels, decreased or absent natural
killer (NK) cell activity, and hemophagocytosis in the bone
marrow, spleen, or lymph nodes.13 In our case, diagnosis
was based on the presence of five of these criteria.
Our patient had an abnormal presentation, with fever and
colicky abdominal pain. Willekens et al14 described a patient
with fulminant HLH induced by pandemic A (H1N1) influenza
who also presentedwith predominantly digestive symptoms.
The child in our case developed dramatic and severe
HLH and lethal MOF on the 2nd day after hospital admission.
The mechanisms leading to HLH, MOF, and death in patients
infected with influenza are not yet well understood. Un-
controlled dissemination of the virus, with a parallel
excessive inflammatory reaction, causes extensive and
disseminated tissue damage, which damages the lungs,
liver, and brain.15 More specifically, a “cytokine storm”,
along with elevated plasma levels of sIL-2R and other in-
flammatory mediators, and an accumulation of activated T-
lymphocytes and macrophages in various organs, frequently
results in MOF and death.
Several treatment options for HLH have been reported,
with the immediate aim of suppressing uncontrolled
hyperinflammation with immunosuppressive/immunomod-
ulatory agents or cytotoxic drugs. As in our case, IVIG is one
of the options for treatment of severe life-threatening virus-
associated hemophagocytic syndrome (VAHS). The dosage
and duration of IVIG therapy ranges from 400 mg/kg/day for
5 days to 1 g/kg/day for 2 days.16 In our case, a combination
of IVIG and methylprednisolone failed to prevent the death
of the child. Effective treatment of HLH with cyclosporine,
intravenous cyclophosphamide, and an IL-1 receptor
antagonist has been demonstrated in reported cases.
Early diagnosis of VAHS is a clinical challenge that re-
quires a high index of suspicion. The diagnosis is often
delayed due to a variety of factors, including the rarity of
HLH, the complexity of the diagnostic criteria, and concerns
regarding the specificity of the current diagnostic criteria.
One hypothesis is that early treatment with antiviral
drugs may improve survival in patients with VAHS-associated
influenza A (H5N1) virus infection.17 Ozdemir et al8 reportedsuccessful treatment with peroral oseltamivir in a patient
with HLH after infection with influenza A (H1N1) virus. Very
recently, Asai et al18 reported a case of severe influenza A
(H1N1) pneumonia complicated with VAHS that was suc-
cessfully treated using a combination of steroid pulse,
erythromycin IV, and anti-influenza drugs. Introduction of
antiviral agents in some cases of viral-induced HLH was
associated with a better clinical outcome.19,20 The failure to
introduce anti-influenza drugs in our case may be due to the
fulminant course of HLH and the very rapid deterioration of
the patient’s condition.
In conclusion, HLH with MOF is a very rare condition that
can be induced by the novel H1N1 influenza variant. It may
have an unusual initial presentation and follow a very
aggressive and fatal course. Physicians should be aware of
this possibility to allow for early recognition and treatment.References
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